NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

BrmeA.18162.a: 2-haloalkanoic acid dehalogenase i (EC 3.8.1.2)

Target Characteristics

from organism: Brucella melitensis 16M
most recent status: purified
center reference id: BrmeA.18162.a
is community request: True
associated disease: Brucellosis
NIH risk group: 3
is select agent: False
NIH priority
pathogens category:
IIIB

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
BrmeA.18162.a.A1.GE33766 full length 1 205 GE33766
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
BrmeA.18162.a.A1.PS01367 full length 1 205

External Resources

Resource Reference ID
OrthoMCL: OG5_169910
PATRIC ID: fig|224914.11.peg.1609
RefSeq: NP_540360.1
UniProt: Q8YFS7

Enzyme & Pathway Information

Pathway Pathway ID EC Number
2-chloroacrylate degradation I PWY-7425 3.8.1.2

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MNSSPVKHVV FDIGKVLIHY DPELAFLDII PDAGERRWFL ENICTSAWNI EQDRGRSWQE AEALLLESHP QHHDHIRAFR RNWSRMVPHA YDDSVEILRG LIAAGHDVTM LTNFASDTFR EAQARFPFLT ESRGVTVSGD IRLIKPDRAI YDHHVASFGL DPAATLFIDD TMHNVEGAKQ AGWQAVHFTS AAKLADDLRA RQLSF

NT Sequence
ttgaacagta gcccggtcaa acatgtcgtt ttcgatatcg gcaaggtgct cattcactat gatccggaac ttgcctttct ggatatcatt cctgatgctg gcgaacggcg ctggtttctg gaaaatatct gcaccagcgc gtggaacatc gaacaggatc gcgggcgaag ctggcaggaa gccgaagccc tgcttctgga aagccacccg caacatcacg accatatccg cgctttccgc cggaactgga gccgcatggt gccccatgcc tatgacgaca gcgttgaaat cctgcgcggg ctcattgcgg ctggccacga cgtgaccatg ctcaccaatt tcgcatccga tacattccgg gaagcacagg cccgctttcc cttcctgacc gaaagccgtg gcgtgacggt ttcaggcgat atccgcctca tcaaacccga ccgggcgatc tacgatcatc acgtcgcctc gttcggcctc gatccggcag caacgctctt catcgatgac acgatgcaca atgtggaagg tgcgaagcaa gcgggctggc aggcggtgca ttttaccagc gcagccaaac tggccgacga tttgcgggcg cgacagcttt ctttctga

© 2019 Center for Infectious Disease Research. All rights reserved. Contact ssgcid@cidresearch.org with questions or feedback.